β-catenin regulates expression of cyclin D1 in colon carcinoma cells

Nature

Volumn 398, Issue 6726, 1999, Pages 422-426

  Tetsu, Osamu ^a   McCormick, Frank ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL TRANSFORMATION; COLON CARCINOMA; COLON POLYPOSIS; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL;

BETA CATENIN; BINDING SITES; BLOTTING, WESTERN; CELL DIVISION; COLONIC NEOPLASMS; CONSENSUS SEQUENCE; CYCLIN D1; CYTOSKELETAL PROTEINS; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; LUCIFERASES; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); RAS PROTEINS; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

CYTOMEGALOVIRUS;

EID: 0033119801     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/18884     Document Type: Article

References (28)

1. Kinzler, K. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159-170 (1996).
2. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B. & Polakis, P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl Acad. Sci. USA 92, 3046-3050 (1995).
3. Korinek, V. et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma. Science 275, 1784-1787 (1997).
4. Morin, P. et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275, 1787-1790 (1997).
5. Rubinfeld, B. et al. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275, 1790-1792 (1997).
6. Zurawel, R., Chiappa, S., Allen, C. & Raffel, C. Sporadic medulloblastomas contain β-catenin mutations. Cancer Res. 58, 896-899 (1998).
7. Voeller, H., Truica, C. & Gelmann, E. β-catenin mutations in human prostate cancer. Cancer Res. 58, 2520-2523 (1998).
8. Kawanishi, J. et al. Loss of E-cadherin-dependent cell-cell adhesion due to a mutation of the β-catenin gene in a human cancer cell line, HSC-39, Mol. Cell. Biol. 15, 1175-1181 (1995).
9. Miyoshi, Y. et al. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving Exon 3. Cancer Res. 58, 2524-2527 (1998).
10. De La Coste, A. et al Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas, Proc. Natl Acad. Sci. USA 95, 8847-8851 (1998).
11. Molenaar, M. et al. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 86, 391-399 (1996).
12. Behrens, J. et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382, 638-642 (1996).
13. Clevers, H. & Grosschedl, R. Transcriptional control of lymphoid development: lessons from gene targeting. Immunol. Today 17, 336-343 (1996).
14. van de Wetering, M. et al. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88, 789-799 (1997).
15. Geise, K., Kingsley, C., Kirshner, J. & Grosschedl, R. Assembly and function of a TCR-alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9, 995-1008 (1995).
16. Huber, O. et al. Nuclear localization of β-catenin by interaction with transcription factor LEF-1. Mech. Dev. 59, 310 (1996).
17. van der Heyden, M. et al. Identification of connexin43 as a target for wnt signaling. J. Cell Sci. III, 1741-1749 (1998).
18. Riese, J. et al. LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic. Cell 88, 777-787 (1997).
19. Brannon, M., Gomperts, M., Sumoy, L., Moon, R. & Kimelman, D. A β-catenin/XTcf-3 complex binds to the siameis promoter to regulate dorsal axis specification in Xenopus. Genes Dev. 11, 2359-2370 (1997).
20. McKendry, R., Hsu, S., Harland, R. & Grosschedl, R. LEF-1/TCF proteins mediate Wnt-inducible transcription from the Xenopus Nodal related 3 promoter. Dev. Biol. 192, 420-431 (1997).
21. He, T. et al. Identification of c-myc as a target of the APC pathway. Science 281, 1509-1512 (1998).
22. Arber, N. et al. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110, 669-674 (1996).
23. Arber, N. et al. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res. 57, 1569-1574 (1997).
24. Motokura, T. & Arnold, A. PRAD1/cyclin D1 proto-oncogene: genomic organization, 5'DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chromosom. Cancer 7, 89-95 (1993).
25. Albanese, C. et al. Transforming p21ras mutants and c-ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270, 23589-23597 (1995).
26. Zhang, T. et al. Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. Cancer Res. 57, 169-175 (1997).
27. Quelle, D. et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7, 1559-1571 (1993).
28. Lahti, J. et al. Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1. J. Biol. Chem. 272, 10859-10869 (1997).